Study on Serum Zinc and Selenium Levels in Epileptic Patients

January 5, 2013 updated by: Dr. Farahani Heidar, Arak University of Medical Sciences

Arak University of Medical Sciences , Ministry of Health and Education,I.R.Iran

This study was carried out with the purpose of evaluating zinc and selenium levels in serum of epileptic patients and compare with normal individuals.

Study Overview

Status

Completed

Conditions

Detailed Description

Forty patients aged 18 to 50 years visiting Vali-Asr hospital in Arak, I.R. Iran, who were diagnosed with generalized form of epilepsy by a neurologist for the first time were recruited as cases. The control group (n=40) was selected from healthy individuals, in whom no disease was diagnosed until this study, and were matched to the case group by age, sex, and economical status.

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

all generalized and single epileptic patiants which were identify for fist time

Description

Inclusion Criteria:

New generalized and single epileptic cases patients who accept and sign the approval form of ethical committee non smoker, no trauma, no use of selenium supplement, no use of zinc supplement, no use of vitamin A supplement, no use of vitamin D supplement, no Weight loss, no Diarrhea, no addiction, no alcohol consumption, no use of certain medications,

Exclusion Criteria:

presence of above criteria as well as, generalized and single epileptic cases under treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Zinc level (micro gram per deciliter)
In all cases
Selenium level (micro gram per deciliter)
In all cases
Zinc level in male (micro gram per deciliter)
Selenium level in male (micro gram per deciliter)
Zinc level in Female (micro gram per decilitre)
Selenium level in Female (micro gram per decilitre)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Study on Serum Zinc and Selenium Levels in Epileptic Patients
Time Frame: 5 months
decrement in serum zinc and selenium level
5 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Comparison between the selenium levels by gender in two groups
Time Frame: 5 months
5 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Arak University of Medical Sciences

Investigators

  • Principal Investigator: Heidar N Farahani, PhD, Department of Biochemistry,Arak medical sciences university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2011

Primary Completion (ACTUAL)

March 1, 2012

Study Completion (ACTUAL)

May 1, 2012

Study Registration Dates

First Submitted

January 5, 2013

First Submitted That Met QC Criteria

January 5, 2013

First Posted (ESTIMATE)

January 9, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

January 9, 2013

Last Update Submitted That Met QC Criteria

January 5, 2013

Last Verified

January 1, 2013

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • f110@1958
  • f110@19588 (OTHER: ministry of health and education I.R.Iran)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Generalized Epileptic

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe